BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2021
View Archived Issues
FDG-PET signal is substantially affected by microglial glucose uptake in neurodegenerative diseases
Read More
New spondyloarthritis therapeutic target identified
Read More
Elevated plasma CXCL16 levels found in severe COVID-19 patients
Read More
LRFN1 gene as a possible cause of autism spectrum disorder
Read More
Discovery of broad-spectrum inhibitor of oncogenic BRAF dimerization
Read More
Role of de novo mutations in severe male infertility
Read More
Hutchison MediPharma patents new CSF1R inhibitors
Read More
Chinese researchers disclose new ROS inhibitors
Read More
Whole exome sequencing analysis identifies novel genes associated with osteoarthritis
Read More
Angiex presents new TM4SF1-targeting PROTACs
Read More
Dongguan Hec New Drug Research and Development synthesizes new HBV antivirals
Read More
Medshine Discovery describes new compounds for cancer
Read More
Alu RNA induces retinal pigment epithelium degeneration in geographic atrophy via the inflammasome
Read More
Mitochondrial augmentation: a promising disease-modifying strategy for mitochondrial DNA disorders
Read More
NPAS3 identified as a risk gene for autism spectrum disorder
Read More
Tango Therapeutics' MTAPnull PRMT5 inhibitor TNG-908 active in multiple xenograft tumor models
Read More
HLA fine mapping identifies INPP5A as a risk gene for tuberculosis
Read More
Oncodesign and TiumBio collaborate to discover and develop candidates for fibrosis
Read More
Mablink and Emergence enter licensing agreement for ADC targeting Nectin-4
Read More